Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
576 studies found for:    "Diabetic Angiopathies"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
Conditions: Foot Ulcer, Diabetic;   Diabetic Angiopathies
Intervention: Drug: bemiparin (low molecular weight heparin)
2 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
3 Completed Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Retinal Diseases;   Eye Diseases;   Diabetic Angiopathies;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
4 Completed Trial Comparing Different Medical Devices for Infragenual Dilatation
Conditions: Diabetic Angiopathies;   Intermittent Claudication
Interventions: Procedure: Infragenual dilatation;   Procedure: Infragenual dilatation with stenting;   Procedure: Infragenual dilatation with cutting balloon;   Procedure: Laser therapy
5 Unknown  Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
Conditions: Disease Management;   Diabetes Complications;   Diabetic Vascular Complications;   Diabetic Neuropathy;   Diabetic Nephropathy;   Diabetic Retinopathy
Intervention: Other: ADEC Program
6 Completed Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
Condition: Diabetic Vascular Complications
Intervention:
7 Completed
Has Results
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen® pegaptanib sodium
8 Terminated ECM and Blood Components for Wound Healing
Conditions: Ulcer;   Venous Ulcer;   Foot Ulcer, Diabetic
Interventions: Device: ECM;   Biological: Blood Products;   Device: ECM in Blood Products
9 Recruiting Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Other: AMNIOEXCEL;   Other: Standard of Care, Diabetic Foot Ulcers
10 Recruiting Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen Therapy
Condition: Diabetic Peripheral Vascular Disease
Intervention:
11 Active, not recruiting Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Conditions: Diabetic Retinopathy;   Macular Edema
Intervention: Drug: Ranibizumab
12 Unknown  Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
Condition: Diabetic Retinopathy
Intervention: Drug: triamcinolone acetonide
13 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
14 Recruiting Cellular and Tissue Based Therapy Registry
Conditions: Diabetic Foot Ulcers;   Venous Stasis Ulcer;   Pressure Ulcer;   Chronic Non Healing Wound;   Surgical Wound Dehiscence
Intervention: Biological: Cellular and tissue based products
15 Completed Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
Conditions: Diabetes Mellitus;   Diabetic Retinopathy;   Vitreous Hemorrhage
Intervention: Procedure: Intravitreal long acting gas (10% C3F8)
16 Active, not recruiting Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
Conditions: Central Retinal Vein Occlusion;   Proliferative Diabetic Retinopathy
Intervention: Drug: Intravitreal Aflibercept Injection
17 Unknown  Bioburden Reduction of Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer
Intervention: Device: Noveon laser
18 Completed Diabetic Retinopathy Vitrectomy Study (DRVS)
Conditions: Diabetic Retinopathy;   Retinal Detachment;   Vitreous Hemorrhage
Intervention: Procedure: Vitrectomy
19 Completed Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Conditions: Diabetic Foot Ulcer;   Infection
Intervention: Drug: Plurogel PN
20 Completed Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers
Conditions: Platelet-Derived Growth Factor;   Diabetic Foot;   Neoplasms
Intervention: Drug: Sterile becaplermin gel vs. sterile placebo gel treatment 1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years